Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study)

Tocilizumab, a humanized monoclonal antibody to the interleukin 6 (IL-6) receptor, was approved for use as rheumatoid arthritis (RA) therapy in Japan in 2008, but its efficacy and tolerability in daily practice has not yet been reported. We report the results of a multicenter retrospective study on...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yamanaka, Hisashi, Tanaka, Yoshiya, Inoue, Eisuke, Hoshi, Daisuke, Momohara, Shigeki, Hanami, Kentaro, Yunoue, Naoki, Saito, Kazuyoshi, Amano, Kouichi, Kameda, Hideto, Takeuchi, Tsutomu
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Japan 2010
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3071926/
https://ncbi.nlm.nih.gov/pubmed/20953815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10165-010-0366-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky